9a, 11b-dehydro derivatives of 9-oxime-3-keto-6-O- methylerythromycin
    51.
    发明授权
    9a, 11b-dehydro derivatives of 9-oxime-3-keto-6-O- methylerythromycin 失效
    9a,9-肟-3-酮-6-O-甲基红霉素的11b-脱氢衍生物

    公开(公告)号:US06482801B2

    公开(公告)日:2002-11-19

    申请号:US09794381

    申请日:2001-02-27

    Applicant: Yong-Jin Wu

    Inventor: Yong-Jin Wu

    CPC classification number: C07H17/08

    Abstract: The invention relates to compounds of the formula and to pharmaceutically acceptable salts thereof, wherein R1 and R2 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1, methods of using said compounds of formula 1 in the treatment of infections, and methods of preparing said compounds of formula 1.

    Abstract translation: 本发明涉及式的化合物及其药学上可接受的盐,其中R 1和R 2如本文所定义。 本发明还涉及含有式1化合物的药物组合物,使用式1化合物治疗感染的方法,以及制备所述式1化合物的方法。

    Tricyclic erythromycin derivatives
    52.
    发明授权
    Tricyclic erythromycin derivatives 失效
    三环类红霉素衍生物

    公开(公告)号:US06291656B1

    公开(公告)日:2001-09-18

    申请号:US09341888

    申请日:1999-07-15

    Applicant: Yong-Jin Wu

    Inventor: Yong-Jin Wu

    CPC classification number: C07H17/08

    Abstract: The invention relates to compounds of the formula I and to pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I, methods of using said compounds of formula I in the treatment of infections, and methods of preparing said compounds of formula I.

    Abstract translation: 本发明涉及式I化合物及其药学上可接受的盐,其中R 1,R 2,R 3,R 4和R 5如本文所定义。 本发明还涉及含有式I化合物的药物组合物,使用式I化合物治疗感染的方法,以及制备所述式I化合物的方法。

Patent Agency Ranking